Figures & data
Figure 1. SET mechanisms proposed by Silverman et al.Citation16–21.
![Figure 1. SET mechanisms proposed by Silverman et al.Citation16–21.](/cms/asset/5e31d326-e8ad-4891-a192-8c4f49170d02/ienz_a_753882_f0001_b.jpg)
Figure 2. MAO-B inhibitors studied by Silverman et al.Citation34–41.
![Figure 2. MAO-B inhibitors studied by Silverman et al.Citation34–41.](/cms/asset/2165cd01-110b-454b-b092-7c904f6dac4e/ienz_a_753882_f0002_b.jpg)
Figure 3. Reactions modeled to mimic the dissociation of the hypothetical enzyme-inhibitor covalent adducts. Both cis and the trans isomers were modeled for adducts 9–12.
![Figure 3. Reactions modeled to mimic the dissociation of the hypothetical enzyme-inhibitor covalent adducts. Both cis and the trans isomers were modeled for adducts 9–12.](/cms/asset/48e55b04-3a54-4d14-a915-679f14953580/ienz_a_753882_f0003_b.jpg)
Table 1. The length (Å) of breaking and forming bonds for reactants and transition states optimized at B3LYP/6-31G* level and imaginary frequencies of the transition states.
Table 2. Activation energies (kcal/mol) calculated at HF/6-31G* level in gas and aqueous phases, solvation energies (within parentheses) and calculated rate constants (s−1) in aqueous phase.
Table 3. Activation energies (kcal/mol) calculated at B3LYP/6-31G* level in gas and aqueous phases, solvation energies (within parentheses) and calculated rate constants (s−1) in aqueous phase.